C9452 Injection, ceftolozane 50 mg and tazobactam 25 mg

Short descriptor: Inj, ceftolozane/tazobactam

⚠ Terminated HCPCS Level II 2026
Terminated Code
C9452 was terminated as of 2015-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open C9452 in the app →

Look up C9452 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

C9452 is the HCPCS Level II code for Injection, ceftolozane 50 mg and tazobactam 25 mg (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Statute (indicator 53)
Type of Service
Other medical items or services
Effective Date
2016-01-01
Termination Date
2015-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference C9452 with the canonical source and edition:

C9452 — Injection, ceftolozane 50 mg and tazobactam 25 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9452

Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9452

Related Codes in Section C

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial